Aurobindo Pharma Announcements
Intimation of completion of US FDA inspection of Unit II of Eugia Pharma Specialities Limited, Biwadi, a wholly owned subsidiary of the Company.
14 Nov, 2025 | 04:06pm • Source: BSE
Intimation of investors meeting.
14 Nov, 2025 | 11:49am • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about classification of US FDA Inspection at Unit-I of Apitoria Pharma Private Limited as VAI
14 Nov, 2025 | 10:56am • Source:
Intimation of classification of US FDA inspection at Unit-1 of Apitoria Pharma Private Limited.
14 Nov, 2025 | 10:31am • Source: BSE
Submission of earning call transcript.
11 Nov, 2025 | 05:01pm • Source: BSE
Submission of newspaper publication of unaudited financial results.
07 Nov, 2025 | 02:14pm • Source: BSE
Press release on unaudited financial results for the second quarter and half year ended 30.09.2025.
05 Nov, 2025 | 08:03pm • Source: BSE
Presentation on Unaudited Financial Results of the Company for the second quarter and half year ended 30.09.2025
05 Nov, 2025 | 08:00pm • Source: BSE
The Board of Directors of the Company at its meeting held today, November 5, 2025, has, inter alia, considered and approved the standalone and consolidated...
05 Nov, 2025 | 07:52pm • Source: BSE
Announcement of change in Senior Management Personnel.
04 Nov, 2025 | 12:57pm • Source: BSE
Submission of clarification with reference to movement of volume.
30 Oct, 2025 | 03:23pm • Source: BSE
The Exchange has sought clarification from Aurobindo Pharma Ltd on October 30, 2025, with reference to Movement in Volume. <BR><BR>The reply is awaited.
30 Oct, 2025 | 02:41pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
28 Oct, 2025 | 10:53am • Source: NSE
Intimation of plant visit by investor group.
28 Oct, 2025 | 10:39am • Source: BSE
Intimation of the date of Earnings Call on Unaudited Financial Results of the Company for the second quarter and half year ended 30.09.2025.
28 Oct, 2025 | 10:36am • Source: BSE
Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and...
24 Oct, 2025 | 04:05pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about Incorporation of a step down subsidiary in Chile viz Eugia Pharma Chile SpA
23 Oct, 2025 | 10:31am • Source: NSE
Aurobindo Pharma Limited has informed the Exchange about Incorporation of a step down subsidiary viz Aurobindo Pharma Chile SpA
23 Oct, 2025 | 10:29am • Source: NSE
Submission of notice published in newspapers regarding relodgement of transfer requests of physical shares.
16 Oct, 2025 | 12:51pm • Source: BSE
Submission of certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
07 Oct, 2025 | 06:20pm • Source: BSE